Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Inhibition of human melanoma cell growth by the dietary flavonoid fisetin is associated with disruption of Wnt/β-catenin signaling and decreased Mitf levels.

Authors: Syed, Deeba N; Afaq, Farrukh; Maddodi, Nityanand; Johnson, Jeremy J; Sarfaraz, Sami; Ahmad, Adeel; Setaluri, Vijayasaradhi; Mukhtar, Hasan

Published In J Invest Dermatol, (2011 Jun)

Abstract: The prognosis of advanced melanoma remains poor in spite of treatment advances, emphasizing the importance of additional preventive measures. Flavonoids, natural components of our diet, are being investigated for their chemopreventive/therapeutic properties. Microphthalmia-associated transcription factor (Mitf), downstream of the Wnt/β-catenin pathway, has become an important prognostic marker of melanoma. In this study, we show that treatment of 451Lu melanoma cells with the dietary flavonoid fisetin (3,7,3',4'-tetrahydroxyflavone) resulted in decreased cell viability with G1-phase arrest and disruption of Wnt/β-catenin signaling. This was accompanied by a decrease in the expression of Wnt protein and its co-receptors, as well as by a parallel increase in the expression of endogenous Wnt inhibitors. Fisetin-treated cells showed increased cytosolic levels of Axin and β-TrCP and decreased phosphorylation of glycogen synthase kinase 3β associated with decreased β-catenin stabilization. Fisetin-mediated interference with the functional cooperation between β-catenin and T-cell factor (TCF)-2 resulted in the downregulation of positively regulated TCF targets, such as c-myc, Brn-2, and Mitf. Flow-cytometric analysis of Mitf-overexpressing cells showed that fisetin repressed Mitf-induced cell proliferation. Finally, administration of fisetin to 451Lu-xenografted nude mice resulted in the inhibition of tumor development and decreased Mitf expression. Our data suggest that fisetin can be developed as an effective agent against melanoma because of its potential inhibitory effect on β-catenin/Mitf signaling.

PubMed ID: 21346776 Exiting the NIEHS site

MeSH Terms: Animals; Antineoplastic Agents/pharmacology*; Cell Line, Tumor; Cell Proliferation/drug effects; Cell Survival/drug effects; Female; Flavonoids/pharmacology*; G1 Phase/drug effects; Glycogen Synthase Kinase 3 beta; Glycogen Synthase Kinase 3/antagonists & inhibitors; Hepatocyte Nuclear Factor 1-beta/physiology; Humans; Melanoma/drug therapy*; Melanoma/pathology; Mice; Microphthalmia-Associated Transcription Factor/antagonists & inhibitors*; Signal Transduction/drug effects*; Wnt Proteins/physiology*; beta Catenin/analysis; beta Catenin/physiology*; beta-Transducin Repeat-Containing Proteins/physiology

Back
to Top